Peter Johannes Holst
Microbiology and Immunology
University of Copenhagen
Denmark
Biography
Peter Johannes Holst has expertise in developing viral vectored vaccines, genetic adjuvants and animal models. He works at the University of Copenhagen involved in the development of novel vector technologies. An important inspiration has been the technical requirements needed to explore new anti-HIV, which have let to both new T cell and B cell adjuvant technologies. Peter Johannes Holst has expertise in developing viral vectored vaccines, genetic adjuvants and animal models. He works at the University of Copenhagen involved in the development of novel vector technologies. An important inspiration has been the technical requirements needed to explore new anti-HIV, which have let to both new T cell and B cell adjuvant technologies.
Research Interest
Vaccines and Immunology
